Information:
Fel:
ID
13503
Beskrivning
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5)
Nyckelord
Versioner (3)
- 2015-11-05 2015-11-05 -
- 2016-01-02 2016-01-02 -
- 2016-02-11 2016-02-11 -
Uppladdad den
11 februari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Chemotherapy Treatment Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Chemotherapy Treatment Form
- StudyEvent: ODM
Similar models
Chemotherapy Treatment Form
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
CL Item
induction cycle I (1)
C1302181 (UMLS CUI-1)
CL Item
induction cycle II (2)
C1302181 (UMLS CUI-1)
CL Item
post induction cycle III (3)
C1302181 (UMLS CUI-1)
Item Group
Patient Characteristics At Start Cylce
C0683521 (UMLS CUI-1)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Date start treatment
Item
Date start treatment
date
C0808070 (UMLS CUI [1])
CL Item
Idarubicin (1)
C0020789 (UMLS CUI-1)
CL Item
Cytarabin (2)
C0010711 (UMLS CUI-1)
CL Item
Lenalidomide (3)
C1144149 (UMLS CUI-1)
CL Item
Daunorubicin (4)
C0011015 (UMLS CUI-1)
CL Item
Mitoxantrone (5)
C0026259 (UMLS CUI-1)
CL Item
Etoposide (6)
C0015133 (UMLS CUI-1)
Total dose actually given
Item
Total dose actually given
float
C2986497 (UMLS CUI [1])
CL Item
full dose according to schedule (1 )
CL Item
full dose given but start of treatment delayed (2 )
CL Item
daily dose reduced >10% (3 )
CL Item
daily dose reduced and start delayed (4 )
CL Item
not given (5 )
CL Item
interrupted during the cycle and resumed (6 )
CL Item
stopped early (7 )
CL Item
other (specify) (8 )
CL Item
hematological toxicity (1)
C0279810 (UMLS CUI-1)
C0013221 (UMLS CUI-2)
C0013221 (UMLS CUI-2)
CL Item
non-hematological toxicity (specify) (2)
C0013221 (UMLS CUI-1)
CL Item
other (specify) (8)
C0205394 (UMLS CUI-1)
Research Comments
Item
Comments
text
C0947611 (UMLS CUI [1])